Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 28.48
-0.23 (-0.80%)
At close: Feb 12, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 10.41 billion as of February 13, 2026. Its market cap has increased by 12.75% in one year.
Market Cap
10.41B
Enterprise Value
9.14B
Revenue
225.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.48
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 10.41B, a decrease of -16.58%. That is a compound annual growth rate of -6.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 10.41B | 4.19% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 11.40B |
| Chengdu Easton Biopharmaceuticals | 11.23B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 11.06B |
| Chengdu Olymvax Biopharmaceuticals | 11.01B |
| Aurisco Pharmaceutical | 10.78B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.68B |
| Liaoning Chengda Biotechnology | 10.54B |
| Chengzhi | 10.44B |